Discover Thomson Reuters
By
1 Min Read
April 6 (Reuters) – Cerus Corp:
* CERUS CORPORATION PROVIDES UPDATE ON COVID-19 RELATED ACTIVITIES
* CERUS CORP – TRANSITION OF CE MARK SUBMISSION FROM A MEDICAL DEVICE DIRECTIVE FILING TO A MEDICAL DEVICE REGULATION FILING IS EXPECTED IN Q2 OF 2020
* CERUS – UNKNOWN AT THIS TIME WHETHER CE MARK SUBMISSION WILL CONTINUE ITS REVIEW UNDER MDD PATHWAY OR TRANSITION AT SOME LATER POINT TO MDR PATHWAY
* CERUS CORP – CONDUCTING TESTS TO ASSESS EFFICACY OF INTERCEPT IN INACTIVATING SARS-COV-2 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
